{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:06:08Z","timestamp":1790035568548,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.radonc.2023.109505","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T02:57:58Z","timestamp":1675911478000},"page":"109505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial"],"prefix":"10.1016","volume":"181","author":[{"given":"Tianxiang","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangpeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongya","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianli","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109505_b0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1200\/EDBK_209089","article-title":"Precision medicine in non-small cell lung cancer: current standards in pathology and biomarker interpretation","volume":"38","author":"Brown","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.radonc.2023.109505_b0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2004.11.030","article-title":"Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: report of Radiation Therapy Oncology Group (RTOG) protocol 97\u201312","volume":"62","author":"Komaki","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109505_b0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2017.10.042","volume":"100","author":"Jeter","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109505_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2018.02.023","article-title":"ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer","volume":"127","author":"Nestle","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0025","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ijrobp.2004.12.019","article-title":"Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study","volume":"62","author":"De Ruysscher","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109505_b0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13014-016-0698-3","article-title":"Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF)","volume":"11","author":"Li","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0035","article-title":"Involved-field radiotherapy versus elective nodal irradiation in combination with concurrent chemotherapy for locally advanced non-small cell lung cancer: a prospective randomized study","volume":"2013","author":"Chen","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.radonc.2023.109505_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2015.03.014","article-title":"PET\/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014","volume":"116","author":"Konert","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2967\/jnumed.113.131631","article-title":"Differential (18)F-FDG and (18)F-FLT uptake on serial PET\/CT imaging before and during definitive chemoradiation for non-small cell lung cancer","volume":"55","author":"Everitt","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2023.109505_b0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12094-018-1949-6","article-title":"Effect of PET\/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer","volume":"21","author":"Ercelep","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(20)30013-9","article-title":"Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial","volume":"21","author":"Nestle","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0060","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamaoncol.2017.0982","article-title":"Effect of midtreatment PET\/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer: a phase 2 clinical trial","volume":"3","author":"Kong","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0065","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00259-019-04421-5","article-title":"Introducing FDG PET\/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial","volume":"46","author":"Konert","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2023.109505_b0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijrobp.2009.05.028","article-title":"PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings?","volume":"77","author":"Wu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109505_b0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijrobp.2010.09.001","article-title":"Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features","volume":"82","author":"Van Loon","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109505_b0080","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1158\/1078-0432.CCR-17-3427","article-title":"Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy","volume":"24","author":"Marciscano","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2023.109505_b0085","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.21037\/jtd.2017.10.147","article-title":"Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans","volume":"9","author":"Xia","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2023.109505_b0090","first-page":"e466","article-title":"Is a Clinical Target Volume (CTV) necessary in the treatment of lung cancer in the modern era combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?","volume":"8","author":"Kilburn","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.radonc.2023.109505_b0095","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.21037\/tlcr-20-523","article-title":"Is clinical target volume necessary?- a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique","volume":"9","author":"Zou","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.radonc.2023.109505_b0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0105","doi-asserted-by":"crossref","unstructured":"Eaton BR, Pugh SL, Bradley JD, et al. Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617. J Natl Cancer Inst. 2016;108:djw034","DOI":"10.1093\/jnci\/djw034"},{"key":"10.1016\/j.radonc.2023.109505_b0110","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2015.64.8824","article-title":"PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer","volume":"34","author":"Senan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0115","first-page":"1342","article-title":"Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer","volume":"46","author":"Nestle","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2023.109505_b0120","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.2014.59.2360","article-title":"Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer: american society of clinical oncology clinical practice guideline endorsement of the american society for radiation oncology evidence-based clinical practice guideline","volume":"33","author":"Bezjak","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0125","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109505_b0130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1200\/JCO.2013.52.3019","article-title":"Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouse","volume":"32","author":"Mandrekar","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2023.109505_b0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2288-14-72","article-title":"Testing the treatment effect on competing causes of death in oncology clinical trials","volume":"14","author":"Rotolo","year":"2014","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.radonc.2023.109505_b0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2005.09.028","article-title":"Conformity index: a review","volume":"64","author":"Feuvret","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109505_b0150","first-page":"e466","article-title":"Is a Clinical Target Volume (CTV) necessary in the treatment of lung cancer in the modern era combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?","volume":"8","author":"Kilburn","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.radonc.2023.109505_b0155","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3892\/mco.2015.588","article-title":"Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy","volume":"3","author":"Liang","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0160","doi-asserted-by":"crossref","unstructured":"Littbrand B, R\u00e9v\u00e9sz L. The effect of oxygen on cellular survival and recovery after radiation. Br J Radiol. 1969;42:914-924.","DOI":"10.1259\/0007-1285-42-504-914"},{"key":"10.1016\/j.radonc.2023.109505_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2017.06.003","volume":"124","author":"De Ruysscher","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2007.01.006","article-title":"Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located","volume":"82","author":"Zhao","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109505_b0175","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/cncr.24492","article-title":"Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery","volume":"115","author":"Caglar","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109505_b0180","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/thx.2010.141861","article-title":"Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients","volume":"65","author":"Maeda","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.radonc.2023.109505_b0185","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMe1711430","article-title":"Immunotherapy for unresectable stage III non-small-cell lung cancer","volume":"377","author":"Rizvi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2023.109505_b0190","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"PACIFIC investigators. durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:25:04Z","timestamp":1759123504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"alternative-id":["S0167814023000439"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109505","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109505"}}